Literature DB >> 11276549

Statins and bones.

M H Moghadasian1, J J Frohlich.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11276549      PMCID: PMC80878     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  22 in total

Review 1.  Low-density lipoprotein-independent effects of statins.

Authors:  J Davignon; R Laaksonen
Journal:  Curr Opin Lipidol       Date:  1999-12       Impact factor: 4.776

2.  Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study.

Authors:  A E Hak; H A Pols; A M van Hemert; A Hofman; J C Witteman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-08       Impact factor: 8.311

3.  Bisphosphonates act directly on the osteoclast to induce caspase cleavage of mst1 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase.

Authors:  A A Reszka; J M Halasy-Nagy; P J Masarachia; G A Rodan
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

4.  Stimulation of bone formation in vitro and in rodents by statins.

Authors:  G Mundy; R Garrett; S Harris; J Chan; D Chen; G Rossini; B Boyce; M Zhao; G Gutierrez
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

5.  Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering.

Authors:  C P Sparrow; C A Burton; M Hernandez; S Mundt; H Hassing; S Patel; R Rosa; A Hermanowski-Vosatka; P R Wang; D Zhang; L Peterson; P A Detmers; Y S Chao; S D Wright
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-01       Impact factor: 8.311

6.  Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells.

Authors:  M Sugiyama; T Kodama; K Konishi; K Abe; S Asami; S Oikawa
Journal:  Biochem Biophys Res Commun       Date:  2000-05-19       Impact factor: 3.575

7.  Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.

Authors:  K A Chan; S E Andrade; M Boles; D S Buist; G A Chase; J G Donahue; M J Goodman; J H Gurwitz; A Z LaCroix; R Platt
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

8.  HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients.

Authors:  Y S Chung; M D Lee; S K Lee; H M Kim; L A Fitzpatrick
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

9.  HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.

Authors:  P S Wang; D H Solomon; H Mogun; J Avorn
Journal:  JAMA       Date:  2000-06-28       Impact factor: 56.272

10.  HMG-CoA reductase inhibitors and the risk of fractures.

Authors:  C R Meier; R G Schlienger; M E Kraenzlin; B Schlegel; H Jick
Journal:  JAMA       Date:  2000-06-28       Impact factor: 56.272

View more
  1 in total

Review 1.  Statins and menopause.

Authors:  Mohammed H Moghadasian
Journal:  Drugs       Date:  2002       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.